These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22558882)

  • 21. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
    Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
    Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 26. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 27. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 28. Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics.
    Rainer M; Mucke HA; Krüger-Rainer C; Kraxberger E; Haushofer M; Jellinger KA
    J Neural Transm (Vienna); 2001; 108(11):1327-33. PubMed ID: 11768631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs for Alzheimer disease.
    Can Fam Physician; 2005 Nov; 51(11):1485. PubMed ID: 16353830
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of Alzheimer disease.
    Winslow BT; Onysko MK; Stob CM; Hazlewood KA
    Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
    J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy in Alzheimer disease].
    Kovács T
    Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971
    [No Abstract]   [Full Text] [Related]  

  • 35. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear.
    Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119
    [No Abstract]   [Full Text] [Related]  

  • 36. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease].
    García-Díaz JD; Fraguas C; Garcimartín C
    Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247
    [No Abstract]   [Full Text] [Related]  

  • 37. Donepezil abolishes anticholinergic activity in a patient with amnesia.
    Konishi K; Hori K; Tomioka H; Minegishi G; Tani M; Tanaka H; Akita R; Yokoyama S; Oshio T; Hachisu M
    Pharmacology; 2013; 91(1-2):86-91. PubMed ID: 23258422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: Seeing the signs early.
    Leifer BP
    J Am Acad Nurse Pract; 2009 Nov; 21(11):588-95. PubMed ID: 19900220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A; Padovani A; Trabucchi M
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):87-8. PubMed ID: 12497562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.